Research-led perspectives and insights on the science, chemistry and industry decisions shaping pharma development.
Chemistry & DevelopmentFluorine is firmly established in modern small-molecule design. The harder question is when a property gain justifies the synthesis, material and development decisions that follow.
Read the perspective
Industry & MarketsPFAS monitoring is expanding, but specialized materials are not always easy to obtain. The constraint is not simply chemistry: identity, analytical quality, supplier qualification and regulation determine which research needs can be served.
Read the perspective
Science & DiscoveryAs regulators open the door to new approach methodologies, the harder task is to connect biological relevance, exposure, target engagement and safety into evidence that can support a development decision.
Read the perspective